시장보고서
상품코드
1663165

공기압식 네블라이저 시장 규모, 점유율, 성장 분석 : 적응증별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Pneumatic Nebulizers Market Size, Share, and Growth Analysis, By Indication (Breath-Actuated, Vented), By End Use (Hospitals & Clinics, Home Healthcare), By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

공기압식 네블라이저 시장 규모는 2023년 8억 405만 달러로 평가되며, 예측 기간(2025-2032년) 동안 6.7%의 CAGR로 2024년 8억 5,792만 달러에서 2032년 14억 4,133만 달러로 성장할 것으로 예상됩니다.

공기압식 네블라이저 시장은 의료기기 산업의 중요한 구성요소이며 환자의 호흡기 치료 요구를 충족시키는 데 초점을 맞추고 있습니다. 이 장치는 액체 약물을 흡입 가능한 미세한 미스트로 변환하여 천식 및 COPD와 같은 호흡기질환에 대한 치료의 효과적인 전달을 강화합니다. 이러한 질환의 유병률 증가, 인구 고령화, 호흡기 건강 관리에 대한 인식이 높아지면서 시장은 꾸준히 성장하고 있습니다. 또한, 기술 발전으로 인해 휴대가 간편하고 사용하기 쉬운 분무기가 등장하여 수요를 더욱 촉진하고 있습니다. 북미와 유럽이 시장을 주도하고 있지만, 아시아태평양은 대기 오염과 헬스케어 투자 증가로 인해 빠르게 성장하고 있습니다. 필립스 레스피로닉스와 오므론 헬스케어 등 주요 업체들은 환자의 편안함과 약물 전달을 개선하기 위해 혁신을 거듭하며 시장의 지속적인 성장을 보장하고 있습니다.

목차

소개

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 가정과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porters 분석

주요 시장 인사이트

  • 핵심성공요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 사례 연구
  • 규제 상황
  • 특허 분석

공기압식 네블라이저 시장 규모 : 적응증별

  • 시장 개요
  • 호흡 작동형
  • 통기형

공기압식 네블라이저 시장 규모 : 최종 용도별

  • 시장 개요
  • 병원·클리닉
  • 재택 헬스케어

공기압식 네블라이저 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채용한 전략
  • 최근의 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년비 비교(2022-2024년)

주요 기업 개요

  • Philips Healthcare(Netherlands)
  • Omron Healthcare, Inc.(Japan)
  • PARI GmbH(Germany)
  • Drive DeVilbiss Healthcare(USA)
  • Medline Industries, Inc.(USA)
  • Invacare Corporation(USA)
  • GF Health Products, Inc.(USA)
  • Briggs Healthcare(USA)
  • Allied Healthcare Products, Inc.(USA)
  • Aerogen(Ireland)
  • Trudell Medical International(Canada)
  • Salter Labs(USA)
  • Vyaire Medical, Inc.(USA)
  • Besco Medical Co., Ltd.(China)
  • Rossmax International Ltd.(Taiwan)
  • Microlife Corporation(Taiwan)
  • Becton, Dickinson and Company(USA)
  • Teleflex Incorporated(USA)
  • Agilent Technologies, Inc.(USA)
  • ResMed Inc.(USA)

결론과 제안

ksm 25.03.26

Pneumatic Nebulizers Market size was valued at USD 804.05 million in 2023 and is poised to grow from USD 857.92 million in 2024 to USD 1441.33 million by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The pneumatic nebulizers market is a vital component of the medical devices industry, focused on meeting the respiratory care needs of patients. These devices transform liquid medications into a fine mist for inhalation, enhancing the effective delivery of treatments for respiratory conditions like asthma and COPD. The market is experiencing steady growth due to the increasing incidence of such diseases, an aging population, and heightened awareness regarding respiratory health management. Technological advancements have also led to the emergence of portable and user-friendly nebulizers, further driving demand. North America and Europe lead the market, while the Asia-Pacific region is rapidly expanding due to rising air pollution and healthcare investments. Key players, including Philips Respironics and Omron Healthcare, are innovating to improve patient comfort and medication delivery, ensuring the market's continued growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pneumatic Nebulizers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pneumatic Nebulizers Market Segments Analysis

Global Pneumatic Nebulizers Market is segmented by Indication, End Use and region. Based on Indication, the market is segmented into Breath-Actuated and Vented. Based on End Use, the market is segmented into Hospitals & Clinics and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pneumatic Nebulizers Market

The rising incidence of respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis significantly propels the growth of the pneumatic nebulizers market. As these conditions demand efficient medication administration directly to the lungs to aid in symptom relief and disease management, there is an escalating need for advanced nebulizer systems. This trend highlights the vital role pneumatic nebulizers play in providing effective therapy for patients suffering from these chronic respiratory illnesses, thereby driving further innovation and investment in this market segment to meet the growing healthcare demands and improve patient outcomes.

Restraints in the Pneumatic Nebulizers Market

The Pneumatic Nebulizers market encounters significant restraints due to the competition posed by alternative respiratory therapies like inhalers and dry powder inhalers. These alternative devices offer convenience, portability, and ease of use, potentially making them more appealing to patients and healthcare providers. As these options continue to gain popularity, they may hinder the growth of the Pneumatic Nebulizers market. Additionally, advancements in inhaler technology and the increasing emphasis on patient-centric treatment approaches can further challenge the market's expansion. Consequently, the presence of these alternative therapies necessitates a strategic response from Pneumatic Nebulizer manufacturers to maintain their market share.

Market Trends of the Pneumatic Nebulizers Market

The pneumatic nebulizers market is experiencing significant growth driven by notable technological advancements that enhance device efficiency and user experience. Innovations such as quieter operation, accelerated drug delivery times, and optimized particle size distribution are becoming increasingly prevalent, facilitating better therapeutic outcomes for respiratory patients. Manufacturers are focusing on user-friendly designs that cater to diverse patient needs, thereby boosting adoption rates among both healthcare professionals and consumers. As awareness of respiratory conditions grows and the demand for effective treatment solutions increases, the pneumatic nebulizers market is positioned for robust expansion, reflecting broader trends towards improved patient-centric healthcare devices.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Pneumatic Nebulizers Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Breath-Actuated
  • Vented

Global Pneumatic Nebulizers Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinics
  • Home Healthcare

Global Pneumatic Nebulizers Market Size & CAGR (2025-2032)

  • North America (Indication, End Use)
    • US
    • Canada
  • Europe (Indication, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Indication, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Indication, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Indication, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Philips Healthcare (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omron Healthcare, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PARI GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Drive DeVilbiss Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invacare Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GF Health Products, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Briggs Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allied Healthcare Products, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aerogen (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trudell Medical International (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Salter Labs (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vyaire Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Besco Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rossmax International Ltd. (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microlife Corporation (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ResMed Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제